Navigation Links
Symphony Medical Announces First Patient Successfully Treated With Novel Congestive Heart Failure Therapy
Date:4/14/2009

European Trials Commencing for Injectable Biopolymer to Repair Weakened Heart Wall

LAGUNA HILLS, Calif., April 14 /PRNewswire/ -- Symphony Medical, Inc., a developer of novel biopolymer therapies to cardiac abnormalities, announced today that its patented flagship technology, Algisyl-LVR(R), was used on a human for the first time, successfully treating a 50-year-old male who was suffering from chronic heart failure.

The Company intends to sponsor a clinical study of Algisyl-LVR at four centers in Europe, including the German Heart Center in Munich where the first procedure was performed, and is also seeking an Investigational Device Exemption from the U.S. Food and Drug Administration in order to conduct a follow-on U.S. study.

Algisyl-LVR is an implantable medical device under clinical development intended to prevent or reverse the progression of congestive heart failure in patients who have an enlarged left ventricle. The procedure, which is performed on patients undergoing a planned cardiac surgery for mitral valve regurgitation or coronary artery disease, involves injecting a proprietary biopolymer directly into strategic locations of the heart's left ventricle wall. As it is injected, the biopolymer thickens and forms firm, gel-like structures that remain in the heart muscle as permanent implants. These implants act to re-shape the heart, reduce the size of the dilated left ventricle and thicken the damaged wall of the heart, thus returning the heart to a healthier form that facilitates improved cardiac function and performance.

The first Algisyl-LVR patient was successfully treated by Prof. Dr. Robert Bauernschmitt. The condition of the patient, who had been bedridden, was deteriorating due to a poorly performing heart mitral valve which contributed to congestive heart failure. During the surgery to repair the valve, the cardiac surgeon implanted the Algisyl-LVR. Four days following
'/>"/>

SOURCE Symphony, Medical Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Symphony Managemnt Consulting Hires New Solutions Director
2. Angiotech and Symphony Medical Announce Licensing Agreement
3. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
4. NeoStem Completes $11 Million Private Placement Financing to Support Expansion Activities in China, Further Development of NeoStems VSEL Technology and Advancement of Medical Tourism Initiatives
5. Ventus Medical Appoints John McCutcheon as President and CEO
6. New security and medical sensor devices made possible by metallic nanostructures
7. Council for American Medical Innovation Brings U.S. Leaders in Medicine, Biotechnology and Discovery Together in Chicago for Best and Brightest Forum on Medical Innovation
8. China Sky One Medical, Inc. Provides Update on Filing Form 10-K
9. SPO Medical Files Annual Report for Fiscal 2008
10. ArunA Biomedical Submits Contract Proposal to Further Develop Environmental Biosensor for National Security
11. ArunA Biomedical Awarded Department of Defense Contract to Further Develop Environmental Biosensor for National Security

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... to Speak at Economic Club of Canada , ... 2009 -- Ambassador to Speak at Economic Club of C...or for International Investment, and Chairman and ...raphy of David Appia go to www.investinfrance.org...eet with press to discuss recent pro-business init...
(Date:11/25/2009)...Newswire/ - Cytochroma today announced the appoint.... Dr. Moldt will replace Mr. Ulrik Spork as the No...number of Board members remains unchanged at six m...r Moldt to the board and look forward to benefitin...ontinues to make progress in becoming a leading CK...
(Date:11/25/2009)... Reportlinker.com announces that a ...alogue: ,, Brazil Bioethanol Market Analysis a...er.com/p0165503/Brazil-Bioethanol-Market-Analysis-...l Market Analysis and Forecasts to 2013 ,, Sum...and forecasts of the global bioethanol market and ...
(Date:11/24/2009)...man . , Whether it,s CD packaging, container...ncy Identification) are increasingly finding their...label objects or goods and identify them automatic...an read and process the data contained in the labe...uction conditions of up to 100 degrees Celsius. Bu...
Breaking Biology Technology:French Ambassador for International Investment to Visit Toronto December 11 2Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10Intelligence inside metal components 2
...DGE, N.J., Oct. 5 VioQuest,Pharmaceuticals (OTC B...ceutical company focused on acquiring, developing ...announced today that it will,present at the BIO In...p.m.,Pacific Time at the Palace Hotel in the Sea C...uest,s president and CEO, is scheduled to give an,...
...IEW, Calif., Oct. 5 MAP,Pharmaceuticals, Inc. ann...,offering of 5,000,000 shares of common stock at a...ffered by MAP Pharmaceuticals. In addition,MAP Pha... option to,purchase up to an additional 750,000 sh...ch & Co. and Morgan Stanley & Co. Incorporated are...
...EETING, Pa., Oct. 5 Genaera,Corporation (Nasdaq: ...resenting at two upcoming conferences, Biotech 200... InvestorForum in San Francisco on October,9-11, 2...ent and Chief Scientific,Officer of Genaera, is sc..., "Advancing Obesity Therapeutics" to be held at B...
Other Biology Technology:VioQuest Pharmaceuticals to Present at BIO InvestorForum in San Francisco 2VioQuest Pharmaceuticals to Present at BIO InvestorForum in San Francisco 3MAP Pharmaceuticals Announces Pricing of Its Initial Public Offering 2Genaera to Present at Biotech 2007 and BIO InvestorForum 2Genaera to Present at Biotech 2007 and BIO InvestorForum 3
(Date:11/24/2009)...ibed by traditional healers in Brazil to treat a r...o fever and flu. , Now for the first time, resear...ientifically prove the pain relieving properties o...int. , Testing this ancient South American herb o...was able to show that when prepared as a ,tea, th...
(Date:11/24/2009)...derstanding how sounds associated with Navy sonar ... they hear it at all. , The same type of large i...etect flaws in the space shuttle,s behemoth solid ...side the giant head of a whale. The scans are prov...le,s hearing anatomy using a breakthrough method d...
(Date:11/24/2009)...ries from collapsing have been true life-savers. B...eded -- once the arteries are strengthened, they b...ce but to leave them in place. , Prof. Meital Zi...medical Engineering has developed a new patent-pen...re needed, then dissolves. , "Our new composite ...
Breaking Biology News(10 mins):Got a pain? -- Have a cup of Brazilian mint 2Rocket science leads to new whale discovery 2A coating for life 2Senior Quality Lifestyles Corporation Announces Completion of 24164 855 000 in Financing for The Stayton at Museum Way 61232 1Senior Quality Lifestyles Corporation Announces Completion of 24164 855 000 in Financing for The Stayton at Museum Way 61232 2Senior Quality Lifestyles Corporation Announces Completion of 24164 855 000 in Financing for The Stayton at Museum Way 61232 3H1N1 Vaccinations Jam Phone Lines Increased Demand for TimeCenter Online Scheduling Software 61230 1H1N1 Vaccinations Jam Phone Lines Increased Demand for TimeCenter Online Scheduling Software 61230 2The Nations Best Math and Science Students Earn Top High School Honors and Strive for 24100 000 Scholarship 61228 1The Nations Best Math and Science Students Earn Top High School Honors and Strive for 24100 000 Scholarship 61228 2The Nations Best Math and Science Students Earn Top High School Honors and Strive for 24100 000 Scholarship 61228 3
...ews who gripe about poor cabin air quality could h..., hair and clothing. A study in the current issue ... interactions between body oils and ozone found in...emical byproducts that might worsen nasal irritati... air traveler complaints. , In simulated flights ...
...nfects up to 500,000 people in the UK alone, many ...gle biggest cause of people requiring a liver tran...with groups across Europe and the USA, scientists ...lonal antibodies which may be a significant step t...nsive and not successful in all patients. Untreate...
...2007 - The term "biotechnology" elicits a range of...ty. Alan McHughen from the University of Californi...current state public knowledge of biotech, popular...e of the media. How is coexistence dealt with in t...iotech only big companies or also the society at ...
Other Biology News:Skin oil -- ozone interactions worsen air quality in airplanes 2Possible hepatitis C vaccine 2How the public perceives biotech 2
Goat Anti-TNFalpha-IP 2 (G-17) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Goat Anti-Derlin-2 (C-18) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Mouse Anti-Trx-2 Monoclonal Antibody, Unconjugated, Clone 71G4 from Santa Cruz Biotechnology, Inc.
cAMP Competitive immunoassay Assay Kit, HTRF from Cisbio
Biology Products: